Epidemic influenza - Responding to the expected but unpredictable

New England Journal of Medicine

Volumn 368, Issue 7, 2013, Pages 589-592

  Bresee, Joseph ^a   Hayden, Frederick G ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

ANTIBIOTIC RESISTANCE; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SEASONAL VARIATION; SHORT SURVEY; VACCINE FAILURE; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84873629705     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1300375     Document Type: Article

References (5)

1. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:36-44. [Erratum, Lancet Infect Dis 2012;12:655.]
2. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2013. MMWR Morb Mortal Wkly Rep 2013;62:32-5.
3. Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011;365:1406-16.
4. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-10 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013 January 11 (Epub ahead of print).
5. Louie JK, Yang S, Acosta M, et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1) pdm09. Clin Infect Dis 2012;55:1198-204.